Trial NCT04796454

View at ClinicalTrials.gov 
Org. Study IDs: EORTC-1912-GITCG

Last trial update was posted on 2022-06-01

MeSH Interventions

Gemcitabine Oxaliplatin Pamiparib Temozolomide

MeSH Conditions

Biliary Tract Neoplasms Hypersensitivity

Other Conditions

Platinum-Sensitive Biliary Tract Cancer

Stopping Reasons

Company decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID